目的:观察分析头孢地嗪联合氨溴索治疗小儿肺炎的临床疗效。方法:选取我院2012年10月至2013年10月收治的120例小儿肺炎患者,随机分为对照组和实验组,每组各60例,对照组采用头孢地嗪治疗,实验组采用头孢地嗪联合氨溴索治疗,统计对比两组临床有效率,分析研究两组临床疗效。结果:实验组显效22例、有效35例,总有效率95.0%;对照组总有效率71.7%,实验组总有效率明显高于对照组,差异有统计学意义(P<0.05)。实验组肺部哆音消失时间及平均住院时间明显少于对照组,差异有统计学意义(P<0.05)。结论:头孢地嗪联合氨溴索治疗小儿肺炎临床疗效显著,安全性高,值得在临床推广应用。 Objective: To observe and analyze the clinical effect of cefodizime and ambroxol in children with pneumonia. Methods: A total of 120 children with pneumonia admitted from October 2012 to October 2013 in our hospital were randomly divided into control group and experimental group, 60 cases in each group. The control group was treated with cefodizime. The experimental group was treated with cefotidime Triazine combined ambroxol treatment, statistical comparison of two groups of clinical efficiency, analysis of two groups of clinical efficacy. Results: In the experimental group, 22 cases were markedly effective and 35 cases were effective. The total effective rate was 95.0%. The total effective rate in the control group was 71.7%. The total effective rate in the experimental group was significantly higher than that in the control group (P <0.05). The experimental group lung duo disappear time and the average hospital stay was significantly less than the control group, the difference was statistically significant (P <0.05). Conclusion: Cefodizime combined with ambroxol treatment of children with pneumonia clinical significant effect, high safety, it is worth in the clinical application.